Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022 and HZ Efficacy, Immunogenicity and Safety of HZ/su by Frailty Status

NCT03563183 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03563183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03563183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022 and HZ Efficacy, Immunogenicity and Safety of HZ/su by Frailty Status
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 5, 2018
Completion date
April 30, 2019
Enrollment
26,976 (actual)
Sites
169

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster